Correlation Between Cellink AB and Electromedical Technologies

Can any of the company-specific risk be diversified away by investing in both Cellink AB and Electromedical Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cellink AB and Electromedical Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cellink AB and Electromedical Technologies, you can compare the effects of market volatilities on Cellink AB and Electromedical Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cellink AB with a short position of Electromedical Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cellink AB and Electromedical Technologies.

Diversification Opportunities for Cellink AB and Electromedical Technologies

0.57

Correlation Coefficient

Cellink AB  Electromedical Technologies

Very weak diversification

The 3 months correlation between Cellink and Electromedical is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Cellink AB and Electromedical Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Electromedical Technologies and Cellink AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cellink AB are associated (or correlated) with Electromedical Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Electromedical Technologies has no effect on the direction of Cellink AB i.e., Cellink AB and Electromedical Technologies go up and down completely randomly.

Pair Corralation between Cellink AB and Electromedical Technologies

Assuming the 90 days horizon Cellink AB is expected to under-perform the Electromedical Technologies. But the pink sheet apears to be less risky and, when comparing its historical volatility, Cellink AB is 2.86 times less risky than Electromedical Technologies. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Electromedical Technologies is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  0.60  in Electromedical Technologies on September 23, 2024 and sell it today you would lose (0.57) from holding Electromedical Technologies or give up 95.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	99.8%
Values	Daily Returns

Cellink AB  vs.  Electromedical Technologies

Cellink AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cellink AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's forward-looking signals remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Electromedical Technologies

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Electromedical Technologies are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, Electromedical Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cellink AB and Electromedical Technologies

The main advantage of trading using opposite Cellink AB and Electromedical Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cellink AB position performs unexpectedly, Electromedical Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Electromedical Technologies will offset losses from the drop in Electromedical Technologies' long position.

The idea behind Cellink AB and Electromedical Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.